This Vaccine Kills… and NOW They Hit the Brakes?
Let me paint you a picture.
A shiny new vaccine—Ixchiq (cute name, huh?)—gets the FDA’s coveted “accelerated approval.” That means it skips the long line and barrels through regulatory review on a fast pass… even though the long-term risks are basically a mystery.
Then, just months after it hits the market, two elderly men die.
One from encephalitis—his brain inflamed by a vaccine that mimics the very virus it’s meant to protect against. The other was already battling Parkinson’s when his condition worsened after the jab—so much so that he choked to death from aspiration pneumonia.
Suddenly, the FDA and CDC issue a joint recommendation: maybe let’s pause this one for seniors while we “investigate.”
Gee, what a concept—look into adverse events BEFORE the funerals start.
Let’s not kid ourselves. The warnings were already there.
The Ixchiq product label flat out states it may cause “severe or prolonged chikungunya-like reactions.” And the data from the rushed clinical trials? Crystal clear:
- In studies that led to its approval, 1.6% of recipients experienced adverse effects so severe they had to stop daily activities or seek medical care.
- Two people were hospitalized.
- In contrast? Zero people in the placebo group had serious reactions.
(Source: FDA Safety Communication, May 2025)
Still, they greenlit the vaccine.
Then came the 17 serious adverse events post-approval. Six of them here in the U.S., the rest globally. All of them in patients aged 62 to 89.
And let me be clear: this wasn’t a case of one or two flukes. It’s a pattern. A red flag the size of a billboard.
But instead of pulling the vaccine altogether, the agencies opted for a half-measure: just pause it in the age group most likely to drop dead from it.
You know… seniors.
The European Medicines Agency saw the same writing on the wall and echoed the call—restricting use in people 65 and up, since Ixchiq was never properly tested on that group to begin with.
Let me say that again: they approved a live virus vaccine for seniors… without even studying it in seniors.
That’s not medicine. That’s negligence on a global scale.
And yet, we’re supposed to trust these bureaucrats? The same ones who assured us this was safe for travelers and lab workers? The same ones who slap “emergency use” labels on experimental products like they’re handing out coupons?
It’s always the same story: inject first, investigate later.
Don’t forget: these are the same institutions who told you every jab was safe, effective, and essential… until it wasn’t. Who called any criticism “misinformation”… until the body count started stacking up.
Their priorities are clear—and your safety isn’t one of them.
So if you’re over 60 (or frankly, if you have a heartbeat), don’t get swept up in the hype. Don’t let the shiny names and fast-tracked approvals fool you.
You don’t need to be a conspiracy theorist to smell the rot here. Just pay attention.
They only pump the brakes after they’ve driven us into a wall.
And as for Ixchiq? That cute name doesn’t make it any less deadly.
In Your Corner,
Dr. Allan Spreen
In Case You Missed It
